ABC Arbitrage SA acquired a new stake in Zoetis Inc. (NYSE: ZTS) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 14,387 sh

2 Dividend Stocks to Double Up on Right Now

04:35am, Tuesday, 11'th Nov 2025
Bad press has weighed on UnitedHealth Group and Zoetis. UnitedHealth Group faces controversy and investigations, but will likely survive and remain a key cog in America's healthcare system.

What Moved Markets This Week

07:28am, Saturday, 08'th Nov 2025
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Zoetis faces ongoing headwinds as Librela sales disappoint, triggering a sharp post-earnings sell-off and continued stock weakness. Librela's decline, fueled by social media concerns about side effect
Zoetis Inc. is trading at historically low valuations despite continued EPS and margin growth, following a sharp post-earnings selloff. ZTS's Q3 results showed resilient profitability, but weaker guid
Exploring Diamond Hill Capital (Trades, Portfolio)'s Latest 13F Filing for Q3 2025 Diamond Hill Capital (Trades, Portfolio) recently submitted its 13F filing f
Zoetis Inc. ( ZTS ) Q3 2025 Earnings Call November 4, 2025 8:30 AM EST Company Participants Steven Frank - Vice President of Investor Relations Kristin Peck - CEO & Director Wetteny Joseph - Executive
Animal health firm Zoetis Inc. (NYSE:ZTS) on Tuesday reported a third-quarter 2025 adjusted earnings per share of $1.70.
Zoetis tops Q3 earnings forecasts but misses on revenues and trims 2025 sales outlook, sending shares lower on weak U.S. results.

Zoetis: No Longer A Growth Stock

12:41pm, Tuesday, 04'th Nov 2025
Zoetis shares have underperformed, falling over 25% in the past year, with recent guidance disappointing investors. Organic growth is slowing, especially in the United States, as core products reach m
The headline numbers for Zoetis (ZTS) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estima

Zoetis (ZTS) Surpasses Q3 Earnings Estimates

09:11am, Tuesday, 04'th Nov 2025
Zoetis (ZTS) came out with quarterly earnings of $1.7 per share, beating the Zacks Consensus Estimate of $1.62 per share. This compares to earnings of $1.58 per share a year ago.
Zoetis slashes its full-year outlook.
The animal health company now expects just $9.4 billion-$9.475 billion in sales for the year. Zoetis stock tumbled.
Revenue: $2.4 billion, slightly below the estimated $2.410 billion, marking a 1% increase year-over-year.Earnings Per Share (EPS): Reported at $1.63, surpassin
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE